Logo der Gerresheimer AG
Therapeutic Areas

Immunology

Reliable high-end quality outperforming market standards

Setting new standards in our primary packaging and drug delivery device portfolio maintaining excellent quality, while targeting innovative challenges - that's what we strive for.

Facts and figures

> 80 known autoimmune diseases

Gerresheimer is an integrated system & solution provider with the broadest portfolio of primary packaging and drug delivery devices

Approximately 80% of people with a chronic autoimmune condition are women

Best glass vial performance in the market – Gx Elite vials, even for the most demanding drug products

Biologics for Chronic & Autoimmune Diseases

Everyday, our immune system protects us from infections and cancer cells. However, if misdirected, the activation of immune cells can result in damage to organs which can lead to autoimmune diseases, hypersensitivities and chronic inflammation.

Immunotherapy is most commonly used to treat autoimmune disorders such as e. g. Crohn's disease, Hashimoto's thyroiditis, multiple sclerosis and rheumatoid arthritis. With the rise of biotechnologically produced drug products such as monoclonal antibodies, interferons and interleukins treatment options for patients improved.

Cell & Gene Therapies

Within the recent years new technologies of treating rare and genetic diseases arose - cell and gene therapies. Those therapies aim to treat, prevent or potentially cure diseases with the potential to alleviate the underlying cause.

While cell therapy restores or alters certain sets of cells to carry a therapy through the body, gene therapies target the replacement, inactivation or introduction of genes into cells.

Reliable injection of viscous biologics at home

Biologic drugs such as mAbs are effective at treating or managing diseases in a broad range of therapeutic areas. However, delivering these biologic drugs subcutaneously in a home-care setting can be challenging as sensitive biomolecules and viscous formulations place specific demands on a device. We‘ve consulted with pharmaceutical partners and purpose-designed our Gx Inbeneo® single-use autoinjector platforms to respond to these challenges.

Discover more in our whitepaper

Contact the Expert

Zsolt Walter-Mate

Senior Director Sales Europe & Asia Tubular Glass

By submitting this form, your inquiry will be forwarded to the responsible contact person within the Gerresheimer Group (which may be located outside the EU/EEA) for processing. Details regarding data transfer and the recipients can be found in our Privacy Policy.